AB
Alume Biosciences Inc
SEC filingBiotechnology · LA Jolla, CA
Amount raised$2.2Msold at filing
Total offering$8M$5.8M still open
Investors in the raise4count reported to the SEC
FiledMay 8, 2026first sale Mar 24, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Kim KamdarDirector
Jean-Pierre MillonDirector
Kaveri ParkerExecutive Officer
Brett BermanExecutive Officer, Director
Dan BradburyDirector
James SchmidtExecutive Officer
Quyen NguyenExecutive Officer, Director
Magda MarquetDirector
Executive officers, directors and promoters as listed on the Form D.